Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.



The Top 25 Dividend Stocks for 2012: Johnson & Johnson

The following video is part of our "Motley Fool Conversations" series, in which, Eric Bleeker, senior technology editor, and James Early, advisor, discuss topics around the investing world.

In today's edition, James suggests that dividend-focused investors look toward Johnson & Johnson. While there's been a high degree of pessimism surrounding the company as it's faced product recalls and other product missteps, James says the company is essentially a "mutual fund for the health-care industry" and has been unfairly beaten down.

If you're interested in Johnson & Johnson on your quest for great high-yielders, The Motley Fool has compiled a special free report outlining our 11 favorite, dependable dividend-paying stocks. It's called "Secure Your Future With 11 Rock-Solid Dividend Stocks." You can access your complimentary copy today at no cost. Just click here to discover the winners we've picked.

Eric Bleeker owns no shares of the companies listed above. James Early and The Motley Fool own shares of Johnson & Johnson. Motley Fool newsletter services have recommended buying shares of Johnson & Johnson and Pfizer and creating a diagonal call position in Johnson & Johnson. Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Read/Post Comments (1) | Recommend This Article (5)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On December 31, 2011, at 10:09 AM, Stoneaa wrote:

    Here is a list of my best 25 dividend growth picks for 2012:

    + +

    The average price to earnings ratio (P/E ratio) amounts to 15.49 while the forward price to earnings ratio is 13.42. The dividend yield has a value of 3.26 percent. Price to book ratio is 6.95 and price to sales ratio 1.70. The operating margin amounts to 16.34 percent. Last year I made a list of companies with interesting equity stories I love to buy (Here is the link: 25 Top Dividend And Growth Stock Picks For 2011). One year late I reviewed these stocks. They have an impressive year to date performance. The average portfolio generated an average equal weighted return of 12.35 percent without dividend payments. At the beginning of the year, the yield of the portfolio was 3.15 percent. So, the total return of the picks should be around percent 15.5 percent. Not bad if we regard the return of the Dow Jones (5.53 percent), the Standard & Poor’s Index (0 percent) and the year performance from NASDAQ Composite (-1.8 percent).

Add your comment.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 1749237, ~/Articles/ArticleHandler.aspx, 10/26/2016 11:30:15 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated Moments ago Sponsored by:
DOW 18,228.44 59.17 0.33%
S&P 500 2,143.44 0.28 0.01%
NASD 5,280.25 -3.15 -0.06%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

10/26/2016 11:14 AM
JNJ $114.99 Up +1.03 +0.90%
Johnson and Johnso… CAPS Rating: ****
MRK $61.31 Down -0.65 -1.04%
Merck and Co. CAPS Rating: ****
PFE $32.54 Up +0.26 +0.81%
Pfizer CAPS Rating: ****